🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Erin F. Cobain

University of Michigan

ORCID: 0000-0001-9602-8611

Also affiliated with Michigan Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.128Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Tumor/normal genomic profiling in patients with metastatic solid tumors identifies pathogenic germline variants of therapeutic importance.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1501
Top 71%
0.128DataRank
Top 71%1 citations

Michelle F. Jacobs, Yi‐Mi Wu, Dan R. Robinson, Pankaj Vats, Rashmi Chugh +4 more

Papers

Driven by 8 papers — median percentile 14. Top paper: “Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)”.

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063
N/A
0.587DataRank · unranked
12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562
N/A
0.457DataRank · unranked
20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Tumor/normal genomic profiling in patients with metastatic solid tumors identifies pathogenic germline variants of therapeutic importance.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1501
Top 71%
0.128DataRank
Top 71%1 citations

Michelle F. Jacobs, Yi‐Mi Wu, Dan R. Robinson, Pankaj Vats, Rashmi Chugh +4 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384
N/A
0DataRank · unranked
0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076
N/A
0DataRank · unranked
0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Psychological Considerations Associated with Lobular Breast Cancer

Current Psychiatry Reports(2024)10.1007/s11920-024-01578-1
N/A
0DataRank · unranked
3 citations

Shivali Patel, Erin F. Cobain, Celina G. Kleer, Colleen H. Neal, Flora Migyanka +3 more

Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10527
Top 100%
0DataRank
Top 100%0 citations

Yi‐Mi Wu, Dan R. Robinson, James M. Rae, N. Lynn Henry, Daniel F. Hayes +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1
N/A
0DataRank · unranked
0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more